Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (24)

2018

  1. Regulation of energy expenditure and brown/beige thermogenic activity by interleukins: New roles for old actors

    International Journal of Molecular Sciences, Vol. 19, Núm. 9

2015

  1. Divergent responses to thermogenic stimuli in BAT and subcutaneous adipose tissue from interleukin 18 and interleukin 18 receptor 1-deficient mice

    Scientific Reports, Vol. 5

2014

  1. Energy balance regulating neuropeptides are expressed through pregnancy and regulated by interleukin-6 deficiency in mouse placenta

    International Journal of Endocrinology, Vol. 2014

2013

  1. Interleukin 6 Deficiency Modulates the Hypothalamic Expression of Energy Balance Regulating Peptides during Pregnancy in Mice

    PLoS ONE, Vol. 8, Núm. 8

2009

  1. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.

    Thyroid : official journal of the American Thyroid Association, Vol. 19, Núm. 6, pp. 645-649

1995

  1. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats

    Neuroendocrinology, Vol. 61, Núm. 5, pp. 552-558

1993

  1. Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: Evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin

    Neuroendocrinology, Vol. 57, Núm. 6, pp. 1155-1160

  2. Glucocorticoids may inhibit growth hormone release by enhancing β-adrenergic responsiveness in hypothalamic somatostatin neurons

    Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 2, pp. 439-444

1992

  1. Neuroendocrine control of growth hormone secretion in humans

    Trends in Endocrinology and Metabolism

1991

  1. Clonidine pretreatment modifies the growth hormone secretory pattern induced by shortterm continuous GRF infusion in normal man

    Clinical Endocrinology, Vol. 35, Núm. 2, pp. 129-135

  2. Evidence that α2-Adrenergic pathways play a major role in growth hormone (GH) neuroregulation: α2-Adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH Response to GH-Releasing Hormone, while α2-Adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 73, Núm. 2, pp. 251-256

  3. Growth hormone and aging

    Endocrinologia, Vol. 38, Núm. 8, pp. 254-260

  4. Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: Studies with metoclopramide

    Neuroendocrinology, Vol. 53, Núm. 2, pp. 143-149

  5. Testosterone and GHRH gene expression in adult and old rats

    Peptides, Vol. 12, Núm. 2, pp. 309-312

1990

  1. New concepts in the neuroregulation of growth hormone secretion

    Arquivos de Medicina, Vol. 3, Núm. 4, pp. 329-338

  2. α2-adrenergic agonism enhances the growth hormone (gh) response to gh-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 71, Núm. 6, pp. 1581-1588

1989

  1. Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade

    Acta Endocrinologica, Vol. 120, Núm. 1, pp. 31-36

  2. REASONS FOR THE VARIABILITY IN GROWTH HORMONE (GH) RESPONSES TO GHRH CHALLENGE: THE ENDOGENOUS HYPOTHALAMIC‐SOMATOTROPH RHYTHM (HSR)

    Clinical Endocrinology, Vol. 30, Núm. 4, pp. 367-377

1988

  1. Adrenal androgen secretion and dopaminergic activity in Anorexia Nervosa

    Hormone and Metabolic Research, Vol. 20, Núm. 1, pp. 57-60

  2. Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man

    Neuroendocrinology, Vol. 47, Núm. 1, pp. 46-49